Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVATE: Vaginal Microbiome Seeding in C-section Infants
NCT03567707Phase 1Active, not recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2018
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in allergic disease and asthma (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Presence of Sensitization to at Least One Food Allergen at 12 months. Started Nov 2018; status: active, not recruiting.
02
Conditions
allergic diseaseasthma
Beyond the preview
Go deeper on NCT03567707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567707.